Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 25395405)

Published in Glycobiology on October 01, 2014

Authors

Anas M Abdel Rahman1, Michael Ryczko2, Miyako Nakano3, Judy Pawling1, Tania Rodrigues2, Anita Johswich1, Naoyuki Taniguchi4, James W Dennis5

Author Affiliations

1: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Room #988, Toronto, ON, Canada M5G1X5.
2: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Room #988, Toronto, ON, Canada M5G1X5 Department of Molecular Genetics.
3: Disease Glycomics Team, Systems Glycobiology Research Group, Chemical Biology Department, RIKEN-Max Planck Joint Research Center, RIKEN Global Research Cluster, Wako, Saitama 351-0198, Japan Graduate School of Advanced Sciences of Matter, Hiroshima University, Hiroshima 739-8530, Japan.
4: Disease Glycomics Team, Systems Glycobiology Research Group, Chemical Biology Department, RIKEN-Max Planck Joint Research Center, RIKEN Global Research Cluster, Wako, Saitama 351-0198, Japan.
5: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Room #988, Toronto, ON, Canada M5G1X5 Department of Molecular Genetics Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada M5G1X5 dennis@lunenfeld.ca.

Articles cited by this

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A (2008) 11.71

Bidirectional transport of amino acids regulates mTOR and autophagy. Cell (2009) 7.88

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36

The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 6.65

The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science (2010) 6.38

MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis. Nucleic Acids Res (2012) 5.68

Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science (2009) 5.31

Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell (2007) 4.85

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A (2010) 4.18

Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science (2004) 3.73

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature (2013) 3.46

The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev (2010) 3.40

Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell (2005) 2.63

Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med (2000) 2.61

Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res (1991) 2.36

A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol (2012) 2.35

N-Glycans in cancer progression. Glycobiology (2008) 2.35

Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol (1986) 2.02

SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res (2012) 1.46

Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer (2005) 1.46

Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci U S A (1995) 1.44

Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol (1995) 1.31

Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J Biol Chem (1997) 1.12

Prognostic value of beta1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res (1998) 1.11

Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene (1989) 1.07

Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J Biol Chem (1996) 1.05

The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression. Cancer Res (2010) 1.05

UDP-GlcNAc concentration is an important factor in the biosynthesis of beta1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V. Glycobiology (2002) 1.03

Density-dependent lectin-glycan interactions as a paradigm for conditional regulation by posttranslational modifications. Mol Cell Proteomics (2013) 0.98

Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells. Mol Cell Proteomics (2011) 0.98

Using the Flp-In™ T-Rex™ system to regulate GPCR expression. Methods Mol Biol (2011) 0.95

Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice. Glycobiology (2009) 0.91

N-glycosylation is critical for the stability and intracellular trafficking of glucose transporter GLUT4. J Biol Chem (2011) 0.90

Mgat5 and Pten interact to regulate cell growth and polarity. Glycobiology (2007) 0.89

N-glycan remodeling on glucagon receptor is an effector of nutrient sensing by the hexosamine biosynthesis pathway. J Biol Chem (2014) 0.89

Metabolic homeostasis and tissue renewal are dependent on beta1,6GlcNAc-branched N-glycans. Glycobiology (2007) 0.89

Unusually high expression of N-acetylglucosaminyltransferase-IVa in human choriocarcinoma cell lines: a possible enzymatic basis of the formation of abnormal biantennary sugar chain. Cancer Res (1999) 0.88

Hypoxic regulation of glycosylation via the N-acetylglucosamine cycle. J Clin Biochem Nutr (2010) 0.87

A tumor-associated glycosylation change in the glucose transporter GLUT1 controlled by tumor suppressor function in human cell hybrids. J Cell Sci (1995) 0.86

Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry. ACS Chem Biol (2013) 0.85

Genome-scale identification of UDP-GlcNAc-dependent pathways. Proteomics (2008) 0.83

Minimal catalytic domain of N-acetylglucosaminyltransferase V. Glycobiology (2000) 0.83

The adaptor protein p66Shc inhibits mTOR-dependent anabolic metabolism. Sci Signal (2014) 0.82

Suppression of cancer progression by MGAT1 shRNA knockdown. PLoS One (2012) 0.81

Targeted metabolomics in cultured cells and tissues by mass spectrometry: method development and validation. Anal Chim Acta (2014) 0.81

A specific detection of GlcNAcbeta1-6Manalpha1 branches in N-linked glycoproteins based on the specificity of N-acetylglucosaminyltransferase VI. Glycobiology (2006) 0.77

Purification and characterization of UDP-GlcNAc: GlcNAcbeta 1-6(GlcNAcbeta 1-2)Manalpha 1-R [GlcNAc to Man]-beta 1, 4-N-acetylglucosaminyltransferase VI from hen oviduct. J Biol Chem (2000) 0.76